Cormorant Asset Management, LLC Insider Trading $RXDX Prometheus Biosciences, Inc.
Get free email notifications about insider trading for Cormorant Asset Management, LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Cormorant Asset Management, LLC. Cormorant Asset Management, LLC is 10% Owner in PROTEOSTASIS THERAPEUTICS, INC. ($PTI) and 10% Owner in Apellis Pharmaceuticals, Inc. ($APLS) and in Atea Pharmaceuticals, Inc. ($AVIR) and in Avidity Biosciences, Inc. ($RNA) and 10% Owner in Axonics Modulation Technologies, Inc. ($AXNX) and 10% Owner in Turning Point Therapeutics, Inc. ($TPTX) and 10% Owner in Kezar Life Sciences, Inc. ($KZR) and in Prometheus Biosciences, Inc. ($RXDX) and in Rain Therapeutics Inc. ($RAIN) and 10% Owner in Kiniksa Pharmaceuticals, Ltd. ($KNSA) and in Olema Pharmaceuticals, Inc. ($OLMA) and in BioAtla, Inc. ($BCAB) and Director in Biomea Fusion, Inc. ($BMEA).
Cormorant Asset Management, LLC in Prometheus Biosciences, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Cormorant Asset Management, LLC:
Holdings: 1,848,022 shares
Latest Transaction: Mar 18 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Cormorant Asset Management, LLC in Prometheus Biosciences, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, APLS, AVIR, RNA, AXNX, BCAB, BMEA, KZR, KNSA, OLMA, RXDX, RAIN, TPTX, YMTX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 18 2021 | RXDX | Prometheus Bioscie ... | Cormorant Asset Management, LP | Option Exercise | C | 0.00 | 1,084,696 | 0 | 0 | ||
| Mar 18 2021 | RXDX | Prometheus Bioscie ... | Cormorant Asset Management, LP | Option Exercise | C | 0.00 | 763,327 | 0 | 0 | ||
| Mar 18 2021 | RXDX | Prometheus Bioscie ... | Cormorant Asset Management, LP | Buy | P | 19.00 | 375,000 | 7,125,000 | 2,223,022 | 1.8 M to 2.2 M (+20.29 %) | |
| Mar 18 2021 | RXDX | Prometheus Bioscie ... | Cormorant Asset Management, LP | Buy | C | 0.00 | 1,848,022 | 0 | 1,848,022 | 0 to 1.8 M |
Page: 1